Rocket Pharmaceuticals Ownership & Insider Activity

Rocket Pharmaceuticals (RCKT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.2% of shares outstanding. Institutional investors hold 37.4%. Over the past 90 days, insiders made 7 sales worth $432K.

Shares Outstanding

109.775M

Shares Float

89.565M

Insider Shares Owned

4.606M

Insider % Owned

4.2%

Institutional Shares Held

41.075M

Institutional % Held

37.4%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$432K total

Net Activity

Net Selling

Net Value (90d)

-$432K

Rocket Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 11, 2026	Martin Wilson	GENERAL COUNSEL	SELL	75.364K	$3.40	$256K
Aug 18, 2026	Martin Wilson	GENERAL COUNSEL	SELL	631.000	$3.38	$2K
Aug 18, 2026	Gaurav Shah	CEO	SELL	2.293K	$3.38	$8K
Aug 13, 2026	Gaurav Shah	CEO	SELL	2.837K	$3.38	$10K
Aug 13, 2026	Martin Wilson	GENERAL COUNSEL	SELL	3.493K	$3.38	$12K
Aug 11, 2026	Christopher James Stevens	CHIEF OPERATING OFFICER	SELL	36.658K	$3.50	$128K
Aug 11, 2026	Sarbani Chaudhuri	SEE REMARKS	SELL	4.701K	$3.50	$16K
May 21, 2026	Gaurav Shah	CEO	SELL-OPTIONS	20.806K	$2.39	$42K
May 19, 2026	Gaurav Shah	CEO	SELL	2.409K	$3.01	$7K
May 19, 2026	Martin Wilson	GENERAL COUNSEL	SELL	662.000	$3.01	$2K
May 19, 2026	John Militello	SEE REMARKS	SELL	384.000	$3.01	$1K
May 13, 2026	Martin Wilson	GENERAL COUNSEL	SELL	3.361K	$3.61	$12K
May 13, 2026	Gaurav Shah	CEO	SELL	2.728K	$3.61	$10K
May 13, 2026	John Militello	SEE REMARKS	SELL	855.000	$3.61	$3K
May 7, 2026	Sarbani Chaudhuri	SEE REMARKS	SELL	17.650K	$3.84	$68K